Two randomized trials have evaluated the addition of bevacizumab, an antibody targeting vascular endothelial growth factor to standard first-line combination chemotherapy.

Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.

A monoclonal antibody targeting the desired antigen can be developed the classical way, using hybridoma technology.

The magnetic nanoparticles are coated with antibodies targeting cancer cells or proteins.

ALX-0081, a single-domain antibody targeting von Willebrand factor is in clinical trials for the prevention of thrombosis in patients with acute coronary syndrome.

-mul-, for example, is never reduced to -mu- because no chimeric or humanized antibodies targeting the musculoskeletal system ever received an INN.

For example, human antibodies targeting the immune system receive names ending in -lumab instead of the old -limumab.

Therefore, the drug is a human monoclonal antibody targeting the immune system.

Instead, it is a contraction from "murine monoclonal antibody targeting CD3".

HuMax is an abbreviation for "human monoclonal antibody targeting...", used by the pharmaceutical company Genmab in trade names.